Who is sponsoring NCT03975881?

NCT03975881 is sponsored by Nantes University Hospital.

What drugs are being tested in NCT03975881?

Interventions in NCT03975881: application on smartphone.

What condition does NCT03975881 study?

NCT03975881 studies Suicide Attempt by Scalding.

Is NCT03975881 still recruiting?

NCT03975881 is currently status unknown. Last updated 5 June 2019.

Last reviewed 2019-06-05 · How we verify

NCT03975881: MED COMPANION

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Study for the Use Smartphone Application to Prevent Suicidal Relapse Among 15-35 Years-old With Previous Suicide Attempted

Status unknown NA Last updated 5 June 2019

What this trial tests

NA trial testing application on smartphone in Suicide Attempt by Scalding in 80 participants. Status unknown.

Timeline

1 June 2019

Primary endpoint
1 December 2020

1 December 2020

Quick facts

Lead sponsor	Nantes University Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	prevention
Enrollment	80
Start date	1 June 2019
Primary completion	1 December 2020
Estimated completion	1 December 2020
Sites	3 locations across France

Drugs / interventions tested

application on smartphone

Conditions studied

Suicide Attempt by Scalding — all drugs for Suicide Attempt by Scalding →

Sponsor

Nantes University Hospital

Who can join

Adults 15 to 35, any sex, with Suicide Attempt by Scalding. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Context: Suicide is the 2nd cause of death during adolescence Compliance with post SA care is low and variable with effective compliance ranging from 17.5% to 47% . Therefore, prevention programs should also focus on high-risk individuals with a previous history of SA. Adolescents and young adults are considered to be digital natives, they are therefore a relevant population for the testing of Smartphone Application. Project: The Investigators propose an innovative and new approach to prevent SA and Suicide for patients, based on a mobile healthcare application. The program is an add-on to the usual care process. Study: In a multicentric randomized pilot study with 15 to 35 years-old patients having previous SA, the primary goal for pilot study is to observe the filling rate of the application (feasibility).

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Prevention of Suicidal Relapses in Adolescents With a Smartphone Application: Bayesian Network Analysis of a Preclinical Trial Using In Silico Patient Simulations.
Mouchabac S, Leray P, Adrien V, Gollier-Briant F, et al · · 2021 · cited 11× · PMID 34591030 · DOI 10.2196/24560

Verify or expand the search:

Other Nantes University Hospital trials

Trials by the same sponsor.

NCT07278661 — Preoperative Use of Romiplostim in Thrombocytopenic Patients Undergoing Cardiac Surgery. · Phase 2 · recruiting
NCT06681363 — Creation of a Biocollection of Patients With Acute Myeloid Leukemia (AML) or Lymphoid Leukemia (ALL) or High-risk Myelod · not yet recruiting
NCT07467382 — GOAT (Gait Observation of Achilles Tendon) · not yet recruiting
NCT07490379 — Comparison of the Efficacy of Transcranial Direct Current Stimulation at Home Versus in Hospital Settings in Patients Wi · NA · not yet recruiting
NCT07423481 — Weight Trajectories and Predictive Factors After Semaglutide in Patients With Grade 3 and Complicated Obesity · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03975881 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Nantes University Hospital
Last refreshed: 5 June 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03975881.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing